Tetraphase Announces Top-Line Results from IGNITE3 Phase 3 Clinical Trial of Eravacycline in Complicated Urinary Tract Infections (cUTI)

World News: . []

WATERTOWN Mass Feb 13 2018 GLOBE NEWSWIRE -- NASDAQTTPH a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening multidrug-resistant MDR infections today announced that its IG NITE3 c...

More news and information about Tetraphase Pharmaceuticals, Inc.

Published By:

Globe Newswire: 21:01 GMT Tuesday 13th February 2018

Published: .

Search for other references to "tetraphase" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us
 

Advertising on SPi News: Information For Advertisers